M. Sextro

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

Norbert Schmitz, Beate Pfistner, M. Sextro et al. · The Lancet · 2002 · 1.1K citations

Medicine, Clinical Sciences, Oncology +13

Clinical Presentation, Course, and Prognostic Factors in Lymphocyte-Predominant Hodgkin's Disease and Lymphocyte-Rich Classical Hodgkin's Disease: Report From the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

Volker Diehl, M. Sextro, Jeremy Franklin et al. · Journal of Clinical Oncology · 1999 · 364 citations · Full text

Medicine, Hematology, Pathology +13

European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.

Ioannis Anagnostopoulos, Martin‐Leo Hansmann, Kaarle Franssila et al. · PubMed · 2000 · 282 citations

Medicine, Oncology, Pathology +14

BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.

Volker Diehl, Jeremy Franklin, Dirk Hasenclever et al. · Journal of Clinical Oncology · 1998 · 196 citations

Medicine, Oncology, Pharmacotherapy +15

Poor clinical outcome of patients with Hodgkin's Disease and elevated interleukin-10 serum levels

Heribert Bohlen, Marcus M. Kessler, M. Sextro et al. · Annals of Hematology · 2000 · 106 citations

Veterinary Medicine, Immunology, Pathology +14